Bondada Engineering Secures CEA Approval for 300 MW Solar Project in Khavda
Bondada Engineering Limited has achieved a critical regulatory milestone with the receipt of energization approval from the Central Electricity Authority (CEA). This clearance pertains to a 300 MW grid-connected solar power project in Khavda, Gujarat, being executed for NLC India Renewables Limited.
Wanbury Ltd Submits DMFs for Global API Launch; Patalganga Unit Receives Zero Observations
Wanbury Limited has initiated expanded regulatory submissions for the global launch of new Active Pharmaceutical Ingredients (APIs). The company filed Drug Master Files for Diphenhydramine HCl and Paroxetine HCl across several international markets while its Patalganga manufacturing facility successfully cleared a Korea MFDS audit.
HDFC Bank Receives RBI Approval for 9.95% Stake in ICICI and Kotak Mahindra Bank
The Reserve Bank of India has permitted HDFC Bank group entities to increase their aggregate shareholding in ICICI Bank and Kotak Mahindra Bank to 9.95%. This regulatory clearance allows units like HDFC Mutual Fund and HDFC Life to maintain strategic investment positions within their normal course of business.
Omaxe Ltd Subsidiary Secures UP RERA Registration for Two Commercial Blocks in Lucknow
Omaxe Ltd’s wholly-owned subsidiary, M/s Omaxe Garv Buildtech Private Limited, has received RERA registration certificates for two commercial blocks in Lucknow, Uttar Pradesh. These approvals for Commercial-3 Block-1 and Block-2 allow the company to commence marketing, sales, and transfer activities for the project through December 2030.
Motilal Oswal Subsidiary MOAMC Receives PFRDA Approval for NPS Pension Fund Sponsor
Motilal Oswal Asset Management Company (MOAMC) has secured a Letter of Appointment from the PFRDA to serve as a Sponsor of a Pension Fund under the National Pension System. This regulatory milestone allows the company to establish a dedicated entity for managing retirement assets, significantly broadening its presence in the pension management sector.
Privi Speciality Chemicals Receives NSE No Objection for Amalgamation Scheme
Privi Speciality Chemicals has cleared a major regulatory milestone by obtaining a 'no objection' observation letter from the National Stock Exchange of India for its proposed merger. The scheme involves integrating Privi Fine Sciences and Privi Biotechnologies into the parent entity to streamline operations and enhance group synergies.
Steel Exchange India Secures 5-Year MES Approval Renewal for SIMHADRI TMT Bars
Steel Exchange India Limited has secured a five-year renewal of approval from the Military Engineer Services (MES), Ministry of Defence, for its SIMHADRI TMT brand. This authorization ensures the company remains an approved supplier for critical government infrastructure and defense projects across India.
Auro Laboratories Secures EDQM Approval for Metformin Hydrochloride Facility at Tarapur
Auro Laboratories has received a formal Attestation of Inspection from the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its MIDC Tarapur facility. This regulatory milestone confirms the site's compliance with European Union Good Manufacturing Practice (GMP) standards for the production of Metformin Hydrochloride.
Auro Laboratories Secures Swissmedic GMP Compliance for Tarapur Plant; Revenue Up 207%
Auro Laboratories Ltd has secured a Certificate of GMP Compliance from Swissmedic for its manufacturing facility in Tarapur, Maharashtra. This approval validates the plant's adherence to international quality standards under the EU-Switzerland Mutual Recognition Agreement, facilitating entry into regulated European markets.